5ykq - Revision history

OCA at 10:33, 14 June 2023

OCA — Wed, 14 Jun 2023 10:33:32 GMT

←Older revision		Revision as of 10:33, 14 June 2023
Line 1:		Line 1:

	==Designed peptide CAY1 from Odorrana andersonii skin secretion==		==Designed peptide CAY1 from Odorrana andersonii skin secretion==
-	<StructureSection load='5ykq' size='340' side='right'caption='[[5ykq~~]], [[NMR_Ensembles_of_Models \| 20 NMR models~~]]' scene=''>	+	<StructureSection load='5ykq' size='340' side='right'caption='[[5ykq]]' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[5ykq]] is a 1 chain structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5YKQ OCA]. For a <b>guided tour on the structure components</b> use [~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=5YKQ FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[5ykq]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Odorrana_andersonii Odorrana andersonii]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5YKQ OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5YKQ FirstGlance]. <br>
-	</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=5ykq FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5ykq OCA], [~~http~~://pdbe.org/5ykq PDBe], [~~http~~://www.rcsb.org/pdb/explore.do?structureId=5ykq RCSB], [~~http~~://www.ebi.ac.uk/pdbsum/5ykq PDBsum], [~~http~~://prosat.h-its.org/prosat/prosatexe?pdbcode=5ykq ProSAT]</span></td></tr>	+	</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5ykq FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5ykq OCA], [https://pdbe.org/5ykq PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5ykq RCSB], [https://www.ebi.ac.uk/pdbsum/5ykq PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5ykq ProSAT]</span></td></tr>
	</table>		</table>
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
Line 20:		Line 20:
	</StructureSection>		</StructureSection>
	[[Category: Large Structures]]		[[Category: Large Structures]]
-	[[Category: ~~Atreya, H S~~]]	+	[[Category: Odorrana andersonii]]
-	[[Category: ~~Bhunia, A~~]]	+	[[Category: Atreya HS]]
-	[[Category: ~~Pal, I~~]]	+	[[Category: Bhunia A]]
-	[[Category: ~~Antimicrobial protein]]~~	+	[[Category: Pal I]]
-	~~[[Category: Cyana 2 1~~]]	+

OCA at 06:55, 27 March 2019

OCA — Wed, 27 Mar 2019 06:55:55 GMT

←Older revision		Revision as of 06:55, 27 March 2019
Line 1:		Line 1:

	==Designed peptide CAY1 from Odorrana andersonii skin secretion==		==Designed peptide CAY1 from Odorrana andersonii skin secretion==
-	<StructureSection load='5ykq' size='340' side='right' caption='[[5ykq]], [[NMR_Ensembles_of_Models \| 20 NMR models]]' scene=''>	+	<StructureSection load='5ykq' size='340' side='right'caption='[[5ykq]], [[NMR_Ensembles_of_Models \| 20 NMR models]]' scene=''>
	== Structural highlights ==		== Structural highlights ==
	<table><tr><td colspan='2'>[[5ykq]] is a 1 chain structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5YKQ OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5YKQ FirstGlance]. <br>		<table><tr><td colspan='2'>[[5ykq]] is a 1 chain structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5YKQ OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5YKQ FirstGlance]. <br>
	</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5ykq FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5ykq OCA], [http://pdbe.org/5ykq PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5ykq RCSB], [http://www.ebi.ac.uk/pdbsum/5ykq PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5ykq ProSAT]</span></td></tr>		</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5ykq FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5ykq OCA], [http://pdbe.org/5ykq PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5ykq RCSB], [http://www.ebi.ac.uk/pdbsum/5ykq PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5ykq ProSAT]</span></td></tr>
	</table>		</table>
		+	<div style="background-color:#fffaf0;">
		+	== Publication Abstract from PubMed ==
		+	The recent rise of multidrug resistant microbial strains requires development of new and novel therapeutic alternatives. In this study, we present a novel antibacterial system that comprises of modified naturally abundant antimicrobial peptides in conjugation with silver nanoparticles. Further, we propose a simple route to incorporate a cysteine residue either at the N- or C-terminal of the parent peptide. Tagging a cysteine residue at the terminals not only enhances the binding propensity of the resultant peptide with the silver nanoparticle, but also increases its antimicrobial property against several pathogenic bacterial strains including K. pneumoniae. The minimum inhibitory concentration (MIC) values of the cysteine tagged nanoconjugates were obtained in the range of 5-15 muM compared to 50 muM for peptides devoid of the cysteines. The origin and mechanism of such improved activity of the conjugates were investigated using NMR spectroscopy and molecular dynamics (MD) simulations. The application of (13)C-isotope labelled media to track the metabolic lifecycle of E. coli cells provided further insights into the system. MD simulations showed that pore formation in membrane bilayer is mediated through a hydrophobic collapse mechanism. The design strategy described herein opens up new-avenues for using biocompatible nanomedicines as a potential alternative to conventional antibiotics.
		+
		+	A Peptide-Nanoparticle System with Improved Efficacy against Multidrug Resistant Bacteria.,Pal I, Bhattacharyya D, Kar RK, Zarena D, Bhunia A, Atreya HS Sci Rep. 2019 Mar 14;9(1):4485. doi: 10.1038/s41598-019-41005-7. PMID:30872680<ref>PMID:30872680</ref>
		+
		+	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
		+	</div>
		+	<div class="pdbe-citations 5ykq" style="background-color:#fffaf0;"></div>
		+	== References ==
		+	<references/>
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
		+	[[Category: Large Structures]]
	[[Category: Atreya, H S]]		[[Category: Atreya, H S]]
	[[Category: Bhunia, A]]		[[Category: Bhunia, A]]

OCA at 06:33, 1 November 2017

OCA — Wed, 01 Nov 2017 06:33:28 GMT

←Older revision		Revision as of 06:33, 1 November 2017
Line 1:		Line 1:
-	'''Unreleased structure'''

-	~~The entry~~ 5ykq ~~is ON HOLD~~	+	==Designed peptide CAY1 from Odorrana andersonii skin secretion==
-		+	<StructureSection load='5ykq' size='340' side='right' caption='[[5ykq]], [[NMR_Ensembles_of_Models \| 20 NMR models]]' scene=''>
-	~~Authors~~: ~~Pal~~, I., ~~Atreya~~, H.S., ~~Bhunia~~, A.	+	== Structural highlights ==
-		+	<table><tr><td colspan='2'>[[5ykq]] is a 1 chain structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5YKQ OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5YKQ FirstGlance]. <br>
-	~~Description: Designed peptide CAY1 from Odorrana andersonii skin secretion~~	+	</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5ykq FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5ykq OCA], [http://pdbe.org/5ykq PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5ykq RCSB], [http://www.ebi.ac.uk/pdbsum/5ykq PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5ykq ProSAT]</span></td></tr>
-	[[Category: ~~Unreleased Structures~~]]	+	</table>
-	[[Category: ~~Atreya~~, ~~H.S~~]]	+	__TOC__
		+	</StructureSection>
		+	[[Category: Atreya, H S]]
		+	[[Category: Bhunia, A]]
	[[Category: Pal, I]]		[[Category: Pal, I]]
-	[[Category: ~~Bhunia, A~~]]	+	[[Category: Antimicrobial protein]]
		+	[[Category: Cyana 2 1]]

OCA: Protected "5ykq" [edit=sysop:move=sysop]

OCA — Wed, 25 Oct 2017 05:38:41 GMT

Protected "5ykq" [edit=sysop:move=sysop]

←Older revision

Revision as of 05:38, 25 October 2017

OCA: New page: '''Unreleased structure''' The entry 5ykq is ON HOLD Authors: Pal, I., Atreya, H.S., Bhunia, A. Description: Designed peptide CAY1 from Odorrana andersonii skin secretion [[Category: U...

OCA — Wed, 25 Oct 2017 05:38:39 GMT

New page: '''Unreleased structure''' The entry 5ykq is ON HOLD Authors: Pal, I., Atreya, H.S., Bhunia, A. Description: Designed peptide CAY1 from Odorrana andersonii skin secretion [[Category: U...

New page

'''Unreleased structure'''

The entry 5ykq is ON HOLD

Authors: Pal, I., Atreya, H.S., Bhunia, A.

Description: Designed peptide CAY1 from Odorrana andersonii skin secretion
[[Category: Unreleased Structures]]
[[Category: Atreya, H.S]]
[[Category: Pal, I]]
[[Category: Bhunia, A]]